WA
IRMD icon

Wasatch Advisors’s iRadimed IRMD Stock Holding History

Wasatch Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-97,000
Closed -$1.65M – 366
2016
Q3 		$1.65M Buy
97,000
+13,000
+15% +$241K 0.02% 272
2016
Q2 		$1.83M Buy
84,000
+30,000
+56% +$540K 0.03% 266
2016
Q1 		$1.04M Buy
54,000
+9,300
+21% +$178K 0.02% 324
2015
Q4 		$1.25M Sell
44,700
-25,300
-36% -$715K 0.02% 316
2015
Q3 		$1.71M Sell
70,000
-30,000
-30% -$718K 0.02% 294
2015
Q2 		$2.33M Sell
100,000
-31,562
-24% -$577K 0.03% 295
2015
Q1 		$2M Sell
131,562
-33,438
-20% -$494K 0.02% 296
2014
Q4 		$2.13M Buy
165,000
+800
+0.5% +$6.91K 0.02% 309
2014
Q3 		$1.15M Buy
+164,200
New +$1.49M 0.01% 350

Other funds holding IRMD

CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wasatch Advisors's IRMD Position: Q4 2016 in Review

Wasatch Advisors sold out of iRadimed (IRMD) in Q4 2016, closing a stake of 97,000 shares — an estimated $1.65M sold.

Wasatch Advisors first reported a position in IRMD in Q3 2014 and held it in 9 quarters. The position peaked at $2.33M in Q2 2015. 58 funds tracked by Wall St. Rank hold IRMD as of Q4 2016.

  • Wasatch Advisors reported no remaining iRadimed position as of Q4 2016 after selling out during the quarter.
  • Wasatch Advisors sold 97,000 iRadimed shares in Q4 2016, an estimated $1.65M.
  • Wasatch Advisors first reported a position in iRadimed in Q3 2014 and held it in 9 quarters.
  • Wasatch Advisors's iRadimed position peaked at $2.33M in Q2 2015.
  • 58 funds tracked by Wall St. Rank held iRadimed as of Q4 2016.

Based on Wasatch Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.